Cardima, Inc.
47266 Benicia Street
Fremont,
CA 94538-7330
United States - Map
Phone: 510-354-0300
Fax: 510-657-4476
Web Site: http://www.cardima.com
| Cardima, Inc., a medical device company, engages in the design, development, manufacture, and marketing of products for the diagnosis and treatment of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. Its therapeutic products include REVELATION mapping catheter, a micro-catheter system designed to map in right and left atria; and REVELATION Tx and REVELATION T-Flex, which are micro-catheter systems with tissue temperature sensors designed to map and create long, thin, continuous, linear, and transmural lesions in the atrium. The companys therapeutic products also comprise REVELATION Helix and REVELATION Helix STX, which are micro-catheter systems with temperature sensors designed to map and create circumferential and focal linear lesions in the pulmonary vein ostia of the left atrium; Surgical Ablation System, a single use cardima surgical ablation probe; and INTELLITEMP and INTELLITEMP EP radio frequency energy management device. Its diagnostic products consist of PATHFINDER, a guide-wire based multi-electrode micro-catheter system designed for accessing coronary sinus vasculature to locate arrhythmia-causing tissue; and PATHFINDER mini, which is designed to provide access to distal and smaller coronary veins. The company sells its products to customers in the electrophysiology and cardiac surgery market segments worldwide. Cardima, Inc. was founded in 1992 and is based in Fremont, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. John Robert Cheney , 51
Chief Exec. Officer, Chief Financial Officer, Director, Member of Nominating Committee and Member of Compensation Committee |
$
0 |
$
0 | Dr. Sung H. Chun M.D., 46
Chief Medical Officer |
N/A
| N/A | Mr. Paul Cheng , 60
Chief Accounting Officer |
$
12.00K | N/A | Dr. Eric K. Y. Chan Ph.D., F.E.S.C., 51
Consultant |
$
200.00K |
$
128.00K | Mr. Chris Mak ,
Controller and Corp. Sec. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
